The IBD world has evolved rapidly during the last decade and we have been facing exciting revolutions in term of genetic, microbiotia and new inflammatory pathways. This has brought new hopes for the treatment of our patients but in the meantime has made our approach of the disease definitively more complex. Defining a therapeutic strategy is the upcoming critical and promising revolution.
Our symposium is divided into State of the Art lectures in the morning and interactive workshops in the afternoon. I hope that you will enjoy !

I would like to thank the Board and EduCom for organizing the program and all our partners for their continuous support.